New York, NY -- (SBWIRE) -- 12/23/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Cincinnati Bell Inc (NYSE:CBB), Athersys, Inc (NASDAQ:ATHX), United Microelectronics Corp (ADR) (NYSE:UMC), Generex Biotechnology Corporation (OTCMKTS:GNBT)
Cincinnati Bell Inc (NYSE:CBB) showed a volume of 3.00 million shares by the end of last trade whereas the average volume of the stock remained 1.33 million shares. The stock opened the session at $3.48 but then moved to $3.60. Cincinnati Bell Inc is a full-service provider of data and voice communications services over wireline and wireless networks, a full-service provider of data center colocation and related managed services, and a reseller of information technology (IT) and telephony equipment. The Company provides telecommunications service to businesses and consumers in the Greater Cincinnati and Dayton areas on its owned wireline and wireless networks.
Is CBB a Solid Investment at These Levels? Read This Report For Details
Athersys, Inc (NASDAQ:ATHX) opened the session at $2.17 and closed the session at $2.17. The stock showed a positive performance of 2.36% in previous trading session. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials. The Company’s clinical development programs are focused on treating inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other conditions.
For How Long ATHX will fight for Profitability? Read This Trend Analysis report
United Microelectronics Corp (ADR) (NYSE:UMC ) opened the session at $2.00 and closed the session at $1.95. Traded with volume of 2.94 million shares in the prior session and the average volume of the stock remained 1.11 million shares. The beta of the stock remained 1.60. United Microelectronics Corp. is principally engaged in the manufacturing of semiconductor products. The Company operates its businesses primarily through wafer production services. The Company provides the customer-tailored design, testing and production of silicon intellectual property (IP) products, embedded integrated circuits (ICs), masks and wafers. The Company offers complementary metal-oxide semiconductor (CMOS) logics, mixed signals, radio frequency (RF) CMOS, embedded memory products, high voltage and CMOS image sensors.
Is UMC a Solid Investment at These Levels? Read This Report For Details
Generex Biotechnology Corporation (OTCMKTS:GNBT) traded with volume of 2.94 million shares in the prior session and the average volume of the stock remained 1.82 million shares. The beta of the stock remained 2.13. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world. The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device.
Is GNBT a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)